Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Onciomed Inc.

www.onciomed.com

Latest From Onciomed Inc.

Obesity Devices: The Next Wave

Several emerging medtechs are developing products and procedures that are less invasive, less expensive, easier to deliver, and more easily reversible than bariatric surgery. With support from investors and the FDA, these firms are poised to reap big rewards in the massive, undermet obesity market.

Medical Device

Obesity 2015: Less Invasive Options Will Drive Growth In Market Hungry For Solutions

Nearly half of the world’s adult population will be overweight or obese by 2030 and obesity is tied to more than 40 diseases. Enterprising companies are heeding the call with increasingly less invasive weight loss devices, while an amenable regulatory environment means the marketplace will welcome some of these innovations in 2015.

Medical Device Innovation

Start-Up Previews, July-August 2014

This Month's Profile Groups: Biopharma In Sweden, features profiles of Northern Light Pharmaceuticals, Sigrid Therapeutics, and Swecure; ENT Devices features profiles of Aerin Medical, ENTvantage Diagnostics, Fiagon, and Spirox. Plus these Start-Ups Across Health Care: Anagnostics Bioanalysis, Check-Cap, Edico Genome, G1 Therapeutics, HeadSense Medical, Innovent Biologics, Navitor Pharmaceuticals, Onciomed, and RevMedx.

BioPharmaceutical Medical Device

Onciomed Inc.

Onciomed Inc. is looking to reduce bariatric surgery complications and the impact of costly co-morbidities with its clinical-stage, minimally invasive, long-term, reversible implant that imitates sleeve gastrectomy without removing a portion of the stomach.

Medical Device Surgical Procedures
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Gastrointestinal
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Onciomed Inc.
  • Senior Management
  • Raj Nihalani, CEO
    Glenn Morimoto, VP, Bus. Dev.
    Paul Stein, Dir., Research
    Lila Cheng, Dir., Fin. & HR
  • Contact Info
  • Onciomed Inc.
    Phone: (714) 658-3039
    15375 Barranca Pkwy.
    Ste. A101
    Irvine, CA 92618
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register